A mechanistic model to predict effects of cathepsin B and cystatin C on β-amyloid aggregation and degradation.

Abstract excerpt

β-Amyloid (Aβ) aggregation is thought to initiate a cascade of neurodegenerative events in Alzheimer's disease (AD). Much effort is underway to develop strategies to reduce Aβ concentration or inhibit aggregation. Cathepsin B (CatB) proteolytically degrades Aβ into non-aggregating fragments but is potently inhibited by cystatin C (CysC). It has been suggested that decreasing CysC would facilitate Aβ clearance by...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cathepsin B
• Share to Cystatin C
• Share to Fluorescence Resonance Energy Transfer